Maciej Sulkowski
Overview
Explore the profile of Maciej Sulkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konieczny P, Adamus T, Sulkowski M, Skrzypek K, Majka M
Cell Death Dis
. 2023 Jan;
14(1):43.
PMID: 36658117
Cervical cancer (CC) is the fourth most common malignant neoplasm among women. Late diagnosis is directly associated with the incidence of metastatic disease and remarkably limits the effectiveness of conventional...
2.
Krzyzak A, Habina-Skrzyniarz I, Mazur W, Sulkowski M, Kot M, Majka M
J Cell Mol Med
. 2022 Jan;
26(5):1501-1514.
PMID: 35076984
The importance of the biophysical characterization of mesenchymal stem cells (MSCs) was recently pointed out for supporting the development of MSC-based therapies. Among others, tracking MSCs in vivo and a...
3.
Sulkowski M, Kot M, Badyra B, Paluszkiewicz A, Plonka P, Sarna M, et al.
Int J Mol Sci
. 2021 Dec;
22(23).
PMID: 34884599
Melanin is a black/brown pigment present in abundance in human skin. Its main function is photo-protection of underlying tissues from harmful UV light. Natural sources of isolated human melanin are...
4.
Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
Chlebanowska P, Sulkowski M, Skrzypek K, Tejchman A, Muszynska A, Noroozi R, et al.
Int J Mol Sci
. 2020 Aug;
21(16).
PMID: 32784894
Neuronal differentiation of human induced pluripotent stem (iPS) cells, both in 2D models and 3D systems in vitro, allows for the study of disease pathomechanisms and the development of novel...
5.
Badyra B, Sulkowski M, Milczarek O, Majka M
Stem Cells Transl Med
. 2020 Jun;
9(10):1174-1189.
PMID: 32573961
Neurological disorders are a massive challenge for modern medicine. Apart from the fact that this group of diseases is the second leading cause of death worldwide, the majority of patients...
6.
Chlebanowska P, Tejchman A, Sulkowski M, Skrzypek K, Majka M
Int J Mol Sci
. 2020 Jan;
21(3).
PMID: 31973095
Organoids are becoming particularly popular in modeling diseases that are difficult to reproduce in animals, due to anatomical differences in the structure of a given organ. Thus, they are a...
7.
Musial-Wysocka A, Kot M, Sulkowski M, Majka M
Int J Mol Sci
. 2019 Sep;
20(18).
PMID: 31540534
In recent years, mesenchymal stem cells (MSCs) have emerged as a promising therapeutic modality in regenerative medicine. They hold great promise for treating civilization-wide diseases, including cardiovascular diseases, such as...
8.
Musial-Wysocka A, Kot M, Sulkowski M, Badyra B, Majka M
Int J Mol Sci
. 2019 Apr;
20(8).
PMID: 31013696
The properties of mesenchymal stem cells (MSCs), especially their self-renewal and ability to differentiate into different cell lines, are widely discussed. Considering the fact that MSCs isolated from perinatal tissues...
9.
Sulkowski M, Konieczny P, Chlebanowska P, Majka M
Int J Mol Sci
. 2018 Jan;
19(1).
PMID: 29315221
Since their invention in 2006, induced Pluripotent Stem (iPS) cells remain a great promise for regenerative medicine circumventing the ethical issues linked to Embryonic Stem (ES) cell research. iPS cells...
10.
Majka M, Sulkowski M, Badyra B, Musialek P
Stem Cells Transl Med
. 2017 Aug;
6(10):1859-1867.
PMID: 28836732
Experimental and early clinical data suggest that, due to several unique properties, mesenchymal stem cells (MSCs) may be more effective than other cell types for diseases that are difficult to...